LCN2 and acute kidney injury: Novel biomarkers of AKI, such as IL-18 and NGAL, may detect AKI within a few hours of the incipient renal pathology, even before ‘traditionally’ used markers like serum creatinine or diuresis rate detect AKI [31, 32].